Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
-
-
-
-
Discovery & DevelopmentCPHI Milan 2026: Overcoming Formulation Barriers in LAIs
4 min read • 6 days ago -
Discovery & DevelopmentNanoform Highlights CESS Benefits Versus Spray-Dried ASDs
4 min read • 1 week ago -
Funding & InvestmentsCodis Appoints Steven Facer in New Role as Chief Commercial Officer
4 min read • 1 week ago -
DealmakingNovo Nordisk Secures Global License to Nanexa’s ALD Drug Delivery Platform
4 min read • 1 week ago -
-
-
-
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.








